Indigenous Australians vulnerable to lupus

December 14, 2012
A new study is currently exploring why Indigenous Australians suffer more frequently and severely from lupus than non-Indigenous Australians.

(Medical Xpress)—A new study is currently exploring why Indigenous Australians (IA) suffer more frequently and severely from lupus than non-Indigenous Australians (NIA).

Affecting more than five million people worldwide, (SLE), known as , is an auto immune illness, meaning the body's immune system attacks the body itself, destroying healthy tissues, particularly the heart, joints, brain, lungs, skin and kidneys.

A scientific review of lupus research in IA, published in the Internal Medicine Journal, reported the prevalence and disease characteristics of lupus in IA differed distinctly from NIA, suggesting the possibility of a distinct and unique immunologic pathway causing this autoimmune disease in Indigenous populations.

Lead author Dr Fabien Vincent, from the Department of Immunology at Monash University, said lupus was up to four times more prevalent in IA compared to NIA, and IA suffered from a more severe form of lupus with a higher numbers of deaths.

"There is a higher prevalence of this illness intrinsic to this particular population and Indigenous Australians appear to have a different set of symptoms of lupus from non-Indigenous Australians," Dr Vincent said.

"Interestingly, prevalence and disease characteristics of lupus also appear to differ between IA communities, depending on the region of Australia.

"In Far North Queensland, compared to non-Indigenous Australians, they have less photosensitivity which is an abnormal reaction of the skin to the sunlight, more renal involvement which means that their is often affected. In the Northern Territory, they have more anti-Sm than non-Indigenous Australians, which are specific to this disease highlighting the abnormal production of antibodies by the body against itself."

Dr Vincent said the potential findings might lead to new that target this distinct pathogenic pathway causing lupus.

"These differences in lupus prevalence, severity and disease manifestation may reflect and be influenced by different genetic and environmental factors such as high ambient ultraviolet exposure and prevalence of infections," Dr Vincent said.

"There's a possibility that environmental factors act as triggers of disease when combined with genetic factors, such as an autoimmune predisposition or susceptibility in Indigenous Australians.

"Considering the genetic-environmental interactions, and not just genetic background, may lead to better knowledge of the underlying causes of lupus in this population. It may also improve the health status of Indigenous and close the health gap between Indigenous and non-Indigenous lupus sufferers."

Explore further: When too much sun is not enough

More information: onlinelibrary.wiley.com/doi/10.1111/imj.12039/abstract

Related Stories

When too much sun is not enough

May 7, 2012

(Medical Xpress) -- Lupus patients show more severe symptoms of the disease if their vitamin D levels are low, an Australian-first study has found.

A surprise mechanism uncovered in the development of lupus

October 25, 2012

In a study with a surprising outcome, scientists at Yale School of Medicine have discovered that an enzyme complex known for promoting natural resistance to bacteria and fungi unexpectedly inhibits the development of lupus. ...

Study: Epstein Barr virus protects against autoimmune disease

April 2, 2012

To the surprise of investigating researchers, an animal model of Epstein Barr virus protected lupus-prone mice against development of the autoimmune disease. Earlier work had suggested that EBV might promote the development ...

Recommended for you

The 'love hormone' may quiet tinnitus

September 23, 2016

(HealthDay)—People suffering from chronic ringing in the ears—called tinnitus—may find some relief by spraying the hormone oxytocin in their nose, a small initial study by Brazilian researchers suggests.

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Mosquitoes, Zika and biotech regulation

September 19, 2016

In a new Policy Forum article in Science, NC State professor Jennifer Kuzma argues that federal authorities are missing an opportunity to revise outdated regulatory processes not fit for modern innovations in biotechnology, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.